Trial intelligence / Profile preview

Effect of Epidural Steroid Injection on BMD in Postmenopausal Women

NCT00941473Phase 4Completed

Sponsor
Henry Ford Health
Start
Jul 2007
Primary completion
Jul 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of triamcinolone in low back pain (LBP), sponsored by Henry Ford Health. Primary endpoints: Bone Mineral Density at 12 months and Markers of Bone Turnover at 12 months. Started Jul 2007; status: completed.

02

Drugs

triamcinolone
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT00941473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00941473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call